Wikipedia:Articles for deletion/Savage Laboratories


 * The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review).  No further edits should be made to this page.

The result was delete. It seems like most sources are not about the topic and that there is only one dedicated source. Jo-Jo Eumerus (talk, contributions) 08:59, 6 October 2019 (UTC)

Savage Laboratories

 * – ( View AfD View log  Stats )

Fails to meet WP:CORP. A search of sources reveal no significant coverage, though some non-significant coverage that references them through their products.

Current references point solely to primary sources. BilledMammal (talk) 07:21, 20 September 2019 (UTC)
 * Note: This discussion has been included in the list of Companies-related deletion discussions. BilledMammal (talk) 07:21, 20 September 2019 (UTC)
 * Note: This discussion has been included in the list of New York-related deletion discussions. Shellwood (talk) 07:37, 20 September 2019 (UTC)
 * Note: This discussion has been included in the list of Medicine-related deletion discussions. North America1000 08:57, 20 September 2019 (UTC)
 * Delete - No references meet WP:ORGCRIT in my online search. --CNMall41 (talk) 02:58, 23 September 2019 (UTC)
 * Comment would the non-significant coverage justify a merge/redirect to Altana? – filelakeshoe (t / c) 🐱 12:44, 27 September 2019 (UTC)

 Relisted to generate a more thorough discussion and clearer consensus.
 * Keep. The company was the subject of an article in The New York Times in 1966 for marketing a dangerous arthritis drug, see here. I also found on my University's library system the articles: "Savage Laboratories Introduces Pandel Cream" by the PR Newswire, March 21, 1997, p.321; "Savage Laboratories Announces a Copromotion Deal with Bioglan Pharma", PR Newswire, Oct 3, 1997, p.1003NYF104; "Savage discontinues Nitrol product line", Pharma Marketletter, April 7, 2003. Their drug Ethiodol is cited quite a lot in published research here. My university library has a ton of other published articles by the company in mulitiple pharmaceutical/medical journals.4meter4 (talk) 00:38, 28 September 2019 (UTC)

Please add new comments below this notice. Thanks,  MBisanz  talk 03:28, 29 September 2019 (UTC)
 * Redirect or Delete. Non-notable. There are exactly zero refs in the article, a Google News search turned up zero sources to support Notability, and even after scanning all ~120 hits in a generic Google search I found zero refs to support Notability. Press releases and other publications by the company itself carry exactly zero weight for Notability, so PR Newswire and most of the other sources cited by 4meter4 don't help. The only potentially promising item is the 1966 New York Times article, which I wasn't able to check. But even if it does provide substantial coverage of Savage Laboratories we would still need multiple solid sources to satisfy Notability. The fact that Savage Laboratories doesn't even warrant a sentence in the parent company article, and there's no content worth merging from the Savage article, just emphasizes how thoroughly non-notable Savage is. A redirect to parent company Altana is possible but very marginal. The sole mention at the target article is the bare name "Savage Laboratories" almost hidden among other names in the infobox Divisions field. Alsee (talk) 22:04, 29 September 2019 (UTC)
 * Delete - Wikipedia is not the yellow pages and shouldn't have completely unsourced articles about companies. &mdash; Rhododendrites  talk \\ 06:04, 2 October 2019 (UTC)
 * Delete I am unable to locate any references that meet the criteria for establishing notability, fails GNG and WP:NCORP. Press releases fail WP:ORGIND.  HighKing++ 13:58, 2 October 2019 (UTC)


 * The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.